Rodriguez-Vallejo JM - Search Results

1

Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older.

Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, del Rosal-Samaniego JM, Rodero-Carcia P, Rodriguez-Vallejo JM. Chicharro-Molero JA, et al. J Urol. 1998 Mar;159(3):878-82. doi: 10.1097/00005392-199803000-00072. J Urol. 1998. PMID: 9474174

2

Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study.

Brock G, Heiselman D, Maggi M, Kim SW, Rodríguez Vallejo JM, Behre HM, McGettigan J, Dowsett SA, Hayes RP, Knorr J, Ni X, Kinchen K. Brock G, et al. Among authors: rodriguez vallejo jm. J Urol. 2016 Mar;195(3):699-705. doi: 10.1016/j.juro.2015.10.083. Epub 2015 Oct 20. J Urol. 2016. PMID: 26498057 Clinical Trial.

3

[Morphologic course of prostatic hyperplasia].

Algaba Arrea F, Trias I, López L, Rodríguez-Vallejo JM, González Esteban J. Algaba Arrea F, et al. Among authors: rodriguez vallejo jm. Actas Urol Esp. 2000 Jun;24(6):463-7. doi: 10.1016/s0210-4806(00)72484-3. Actas Urol Esp. 2000. PMID: 11011428 Spanish.

4

[Benign prostatic hyperplasia and evidence based medicine: its approach in clinical practice].

Carballido Rodríguez JA, Rodríguez Vallejo JM, del Llano Señaris JE. Carballido Rodríguez JA, et al. Among authors: rodriguez vallejo jm. Med Clin (Barc). 2000;114 Suppl 2:96-104. Med Clin (Barc). 2000. PMID: 10916816 Spanish.

5

[Quality of life and symptomatology in benign prostate hyperplasia in active Spanish population].

Gómez Acebo A, Rodríguez Vallejo JM, Rodríguez Mora VI, García Alcázar I. Gómez Acebo A, et al. Among authors: rodriguez vallejo jm. Med Clin (Barc). 2000;114 Suppl 3:81-9. Med Clin (Barc). 2000. PMID: 10994569 Spanish.

6

Neuroendocrine cells in peripheral prostatic zone: age, prostatic intraepithelial neoplasia and latent cancer-related changes.

Algaba F, Trias I, Lopez L, Rodriguez-Vallejo JM, Gonzalez-Esteban J. Algaba F, et al. Eur Urol. 1995;27(4):329-33. doi: 10.1159/000475191. Eur Urol. 1995. PMID: 7656912

7

Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.

Sáez C, González-Baena AC, Japón MA, Giráldez J, Segura DI, Rodríguez-Vallejo JM, González-Esteban J, Miranda G, Torrubia F. Sáez C, et al. Among authors: rodriguez vallejo jm. Prostate. 1999 Jul 1;40(2):83-8. doi: 10.1002/(sici)1097-0045(19990701)40:2<83::aid-pros3>3.0.co;2-n. Prostate. 1999. PMID: 10386468

8

Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR.

Schwartz S Jr, Caceres C, Morote J, De Torres I, Rodriguez-Vallejo JM, Gonzalez J, Reventos J. Schwartz S Jr, et al. Int J Cancer. 1998 May 18;76(4):464-7. doi: 10.1002/(sici)1097-0215(19980518)76:4<464::aid-ijc3>3.0.co;2-p. Int J Cancer. 1998. PMID: 9590118 Free article.

9

[Primary care physicians and prostatic disease. National survey. Members of the Spanish Council of Prostatic Health].

Jiménez Cruz JF, Rodríguez Vallejo JM, Conejero J, Resel L, Rioja LA, Vela Navarrete R, Vicente J. Jiménez Cruz JF, et al. Actas Urol Esp. 1996 Jul-Aug;20(7):624-9. Actas Urol Esp. 1996. PMID: 8975547 Spanish.

10

[Interpretation of results of clinical trials in benign prostatic hyperplasia].

Millán Rodríguez F, Rodríguez Vallejo JM, Carballido Rodríguez J. Millán Rodríguez F, et al. Among authors: rodriguez vallejo jm. Actas Urol Esp. 2002 Jan;26(1):4-14. doi: 10.1016/s0210-4806(02)72721-6. Actas Urol Esp. 2002. PMID: 11899738 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page